MedPath

Faith-based Approaches in the Treatment of Hypertension (FAITH)

Not Applicable
Completed
Conditions
Hypertension
Registration Number
NCT01065831
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this study is to test the effect of a church-based lifestyle intervention on blood pressure reduction in 400 hypertensive blacks (BP\> 140/90 mm hg).

Detailed Description

This study will test the effectiveness of a church-based lifestyle intervention in improving blood pressure control among 400 hypertensive blacks in a group randomized controlled trial. The lifestyle intervention will be delivered by trained lay health advisers through group-based behavioral counseling and motivational interviewing (MINT-TLC) in 24 predominantly black churches in New York City.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
373
Inclusion Criteria
  • Age 18 years or older
  • Diagnosis of hypertension
  • Self-identified Black or African American
  • SBP > 140 mmHg or DBP > 90 mmHg (based on the average of 3 blood pressure readings); or average SBP > 130 mm Hg or DBP > 80 mm hg (for those with diabetes or kidney disease) at the screening/baseline visits
  • Able to speak English
Exclusion Criteria
  • Unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks).
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Within-individual change in systolic blood pressure and diastolic blood pressure6 months
Secondary Outcome Measures
NameTimeMethod
Levels of physical activity6 months
Percent change in weight6 months
Dietary intake of fruits and vegetables6 months
Proportion of blood pressure control9 months

Trial Locations

Locations (1)

NYU School of Medicine

🇺🇸

New York, New York, United States

NYU School of Medicine
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.